S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
OTCMKTS:IMUN

Immune Therapeutics Stock Forecast, Price & News

$1.71
0.00 (0.00%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.71
$1.71
50-Day Range
$1.70
$3.20
52-Week Range
$1.52
$32.70
Volume
1 shs
Average Volume
1,132 shs
Market Capitalization
$820.80 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.83
30 days | 90 days | 365 days | Advanced Chart
Receive IMUN News and Ratings via Email

Sign-up to receive the latest news and ratings for Immune Therapeutics and its competitors with MarketBeat's FREE daily newsletter.


Immune Therapeutics logo

About Immune Therapeutics

Immune Therapeutics, Inc. is a biopharmaceutical company focused on the licensing and development of prescription medications for humans in Africa, Central and South America, the Caribbean and China. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Winter Park, FL.

Headlines

Immune Therapeutics (OTCMKTS:IMUN) Shares Down 2.9%
November 23, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IMUN
Fax
N/A
Employees
2
Year Founded
N/A

Sales & Book Value

Annual Sales
$110 thousand
Book Value
($16.07) per share

Profitability

Net Income
$1.59 million
Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
426,000
Market Cap
$820.80 thousand
Optionable
Not Optionable

Company Calendar

Today
11/28/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

1.15 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -












Immune Therapeutics (OTCMKTS:IMUN) Frequently Asked Questions

How has Immune Therapeutics' stock price been impacted by Coronavirus?

Immune Therapeutics' stock was trading at $0.0064 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IMUN stock has increased by 26,618.8% and is now trading at $1.71.
View which stocks have been most impacted by COVID-19
.

Who are Immune Therapeutics' key executives?

Immune Therapeutics' management team includes the following people:
  • Kevin J. Phelps, President, Chief Executive Officer, CFO & Director
  • Rudy J. Williams, Chief Operating Officer
  • Fengping Shan, Chief Science Officer
  • Joseph M. Fortunak, Vice President-Global Research & Development
  • Kathleen A. Browne, Controller

What other stocks do shareholders of Immune Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immune Therapeutics investors own include Northwest Biotherapeutics (NWBO), Alexion Pharmaceuticals (ALXN), AK Steel (AKS), Galiano Gold (AKG), Agritek (AGTK), Agenus (AGEN), Affymetrix (AFFX), Advanced Disposal Services (ADSW), Adamis Pharmaceuticals (ADMP) and Analog Devices (ADI).

What is Immune Therapeutics' stock symbol?

Immune Therapeutics trades on the OTCMKTS under the ticker symbol "IMUN."

How do I buy shares of Immune Therapeutics?

Shares of IMUN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Immune Therapeutics' stock price today?

One share of IMUN stock can currently be purchased for approximately $1.71.

How much money does Immune Therapeutics make?

Immune Therapeutics has a market capitalization of $820.80 thousand and generates $110 thousand in revenue each year. The company earns $1.59 million in net income (profit) each year or ($61.94) on an earnings per share basis.

How many employees does Immune Therapeutics have?

Immune Therapeutics employs 2 workers across the globe.

What is Immune Therapeutics' official website?

The official website for Immune Therapeutics is www.immunetherapeutics.com.

Where are Immune Therapeutics' headquarters?

Immune Therapeutics is headquartered at 37 NORTH ORANGE AVENUE SUITE 800M, WINTER PARK FL, 32792.

How can I contact Immune Therapeutics?

Immune Therapeutics' mailing address is 37 NORTH ORANGE AVENUE SUITE 800M, WINTER PARK FL, 32792. The company can be reached via phone at (888) 613-8802 or via email at [email protected].


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected]eat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.